Dr Reddy’s settles patent litigation with Indivior, Aquestive Therapeutics
NEW DELHI: Dr Reddy's Laboratories on Thursday said it has settled patent litigation with Indivior Inc and Aquestive Therapeutics on...
Dr Reddy’s
Dr Reddy’s inks pact with Citius Pharma to sell rights to anti-cancer agent
NEW DELHI: Dr Reddy's Laboratories on Saturday said it has inked a pact with US-based Citius Pharmaceuticals to sell its...
Dr Reddy’s developing new treatment options for Covid-19
NEW DELHI: Drug major Dr Reddy's Laboratories is working on the development of new treatment options for COVID-19 patients which...
Dr Reddy’s in talks with RDIF on Covid-19 vaccine Sputnik V for other countries
NEW DELHI: Dr Reddys Laboratories, which is in a pact with Russian Direct Investment Fund to sell 125 million people...
Shilpa Medicare arm inks pact with Dr Reddy’s to manufacture Russian Covid-19 vaccine Sputnik V
NEW DELHI: Drug firm Shilpa Medicare on Monday said its arm has entered into a definitive agreement with Dr Reddy's...
Apollo, Dr Reddy’s announce Covid-19 vaccination programme with Sputnik V
NEW DELHI: Apollo Hospitals and Dr Reddy's Laboratories on Monday said they are collaborating to initiate a COVID-19 vaccination programme...
Dr Reddy’s Laboratories consolidated net profit dips 29% to Rs 557 crore
NEW DELHI: Dr Reddy's Laboratories on Friday reported 29 per cent decline in consolidated net profit at Rs 557 crore...
Dr Reddy’s rolls out Sputnik V Covid-19 vaccine in India at Rs 995 per dose
NEW DELHI: Dr. Reddy’s Laboratories has announced that the first consignment of imported doses of the Sputnik V vaccine that...
Covid-19 update: Dr Reddy’s expects first lot of Sputnik V vaccine by May end
NEW DELHI: Dr Reddy's Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19...
